Related Experiment Video
Updated: Jan 9, 2026

08:51
Quantification of Coenzyme A in Cells and Tissues
Published on: September 27, 2019
8.8K
Roles of Acid Ceramidase and Its Cofactor in Biotherapeutics
Sisi Zhang1, Christopher Sevinsky1, Jared Watson1
1Regeneron Pharmaceuticals Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591-6706, United States.
Molecular Pharmaceutics
|December 9, 2025
Summary
Activated acid ceramidase degrades polysorbates (PSs), causing instability in protein drugs. Effective purification methods, like column regeneration and UF/DF filtration, prevent this degradation.
Area of Science:
- Biochemistry
- Pharmaceutical Sciences
- Protein Therapeutics
Background:
- Polysorbates (PSs) are critical excipients in biopharmaceutical formulations.
- Lipase and esterase activity can degrade PSs, leading to protein drug instability and particle formation.
- Acid ceramidase was not previously recognized as a PS-degrading enzyme.
Purpose of the Study:
- To investigate the potential of acid ceramidase to degrade polysorbates.
- To identify factors that activate acid ceramidase and influence its PS-degrading activity.
- To determine methods for preventing PS degradation in protein drug purification.
Main Methods:
- Analysis of acid ceramidase activity on aged hydrophobic interaction chromatography (HIC) columns.
- Assessment of saposin D's effect on acid ceramidase activity.
- Evaluation of Ultrafiltration/Diafiltration (UF/DF) for saposin D removal.
Main Results:
- Acid ceramidase can be activated on aged HIC columns, enabling polysorbate degradation.
- Saposin D enhances the lipase activity of activated acid ceramidase, accelerating PS degradation.
- Effective HIC column regeneration prevents acid ceramidase activation; UF/DF removes saposin D.
Conclusions:
- Activated acid ceramidase, particularly with saposin D, poses a risk to polysorbate stability during purification.
- Standard purification protocols involving effective column regeneration and UF/DF filtration mitigate the risk of PS degradation.
- The findings suggest that polysorbate degradation by activated acid ceramidase is unlikely in products purified under current guidelines.
Related Concept Videos
Cofactors and Coenzymes
12.5K
Enzymes are proteins made of amino acids. The functional group of each constituent amino acid catalyzes a wide variety of chemical reactions via ionic interactions or acid-base reactions. However, amino acids cannot catalyze oxidation-reduction and group transfer reactions and need to be aided by non-protein components called cofactors. Cofactors are also referred to as the chemical teeth of an enzyme.
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
12.5K
Cofactors and Coenzymes
86.8K
Enzymes require additional components for proper function. There are two such classes of molecules: cofactors and coenzymes. Cofactors are metallic ions and coenzymes are non-protein organic molecules. Both of these types of helper molecule can be tightly bound to the enzyme or bound only when the substrate binds.
86.8K
The Citric Acid Cycle: Output
10.2K
The citric acid cycle is termed an amphibolic pathway as it operates both anabolically and catabolically. The cyclic reactions balance the flux of the substrates to provide an optimal concentration of NADH and ATP to the cell.
Regulation of Citric Acid Cycle
The citric acid cycle is regulated in several ways, including feedback inhibition, regulation of enzyme activities, and associated anaplerotic or cataplerotic pathways.
The primary substrate of the TCA cycle—acetyl CoA—is...
Regulation of Citric Acid Cycle
The citric acid cycle is regulated in several ways, including feedback inhibition, regulation of enzyme activities, and associated anaplerotic or cataplerotic pathways.
The primary substrate of the TCA cycle—acetyl CoA—is...
10.2K
Phase II Reactions: Acetylation Reactions
736
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
736
The Citric Acid Cycle: Overview
22.3K
In aerobic organisms, the citric acid cycle is the second stage of cellular respiration wherein molecules derived from the breakdown of carbohydrates, proteins, and fats are oxidized into carbon dioxide and energy. This process is also known as the tricarboxylic acid (TCA) cycle as the first product of the cycle, citric acid, contains three carboxyl groups in its structure. Alternatively, this cycle is also referred to as the Krebs cycle, in honor of its discoverer Sir Hans Krebs.
The citric...
The citric...
22.3K
Allosteric Proteins-ATCase
6.4K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.4K

